Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010394
Chunk: 2

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 2
---
 to buy these securities in any jurisdiction where the offer or sale is not permitted.

<div align='center'>Subject to Completion,
dated May 27, 2025</div>

PreliminaryProspectus

<div align='center'>1,375,000 Units
Consisting of an Aggregate of
1,375,000 Common Shares
and
1,375,000 Warrants to Purchase One Common Share

1,375,000 Common Shares Issuable upon the Exercise of the Warrants

Medicus Pharma Ltd.</div>

We are offering on a “best efforts” basis 1,375,000 units (each, a "Unit"), each Unit consisting of one common share of Medicus Pharma Ltd. (the "Company", "we", "us"), no par value, and one warrant to purchase one common share (each, a "warrant") at an assumed public offering price of $7.29 per Unit, which was the closing price our common shares on The Nasdaq Capital Market (“Nasdaq”) on May 23, 2025, for an aggregate offering of 1,375,000 common shares and 1,375,000 warrants and gross proceeds of up to approximately $10 million. The public offering price per Unit will be determined between us and the agent (as defined below) based on market conditions at the time of pricing, and may be at a discount to the then-current market price of our common shares. Therefore, the recent market price of our common shares referenced throughout this preliminary prospectus may not be indicative of the final offering price per Unit. Each warrant is immediately exercisable for one of our common shares at an exercise price of $ per share (or 100% of the price of each Unit sold in the offering) and will expire five years from the date of issuance. The Units will not be certificated and the common shares and warrants comprising the Units are immediately separable and will be issued separately in this offering. Pursuant to this prospectus, we are also offering the 1,375,000 common shares issuable from time to time upon the exercise of the warrants offered hereby.

Our common shares and public warrants, with an exercise price of $4.64 and expiration date of November 15, 2029 (the “Public Warrants”) are listed on Nasdaq, under the symbols "MDCX" and "MDCXW," respectively. The warrants offered hereby will not trade on any U.S. securities exchange and we will not